Publications

Search our bibliography using the filters on the right-hand side.

Displaying 1 through 50 of 250 publications.

Margulis AV, Calingaert B, Kawai AT, Rivero-Ferrer E, Anthony MS. Distribution of gestational age at birth by maternal and infant characteristics in U.S. birth certificate data: informing gestational age assumptions when clinical estimates are not available. Pharmacoepidemiol Drug Saf. 2023 Apr 17. doi: 10.1002/pds.5633

Layton JB, Forns Guzman J, McQuay LJ, Danysh HE, Dempsey C, Anthony MS, Turner ME. Mortality in patients with Parkinson's disease-related psychosis treated with pimavanserin compared with other atypical antipsychotics: a cohort study. Drug Saf. 2023 Feb 1;46(2):195-208. doi: 10.1007/s40264-022-01260-6

Anthony MS, Zhou X, Schoendorf J, Reed SD, Getahun D, Armstrong MA, Gatz J, Peipert JF, Raine-Bennett T, Fassett MJ, Saltus CW, Ritchey ME, Ichikawa L, Shi JM, Alabaster A, Wahdan Y, Wang J, Xie F, Merchant M, Hunter S, Chiu VY, Postlethwaite D, Rothman KJ, Im TM, Chillemi G, Takhar HS, Asiimwe A, Pisa F. Demographic, reproductive, and medical risk factors for intrauterine device explusion. Obstet Gynecol. 2022 Nov 3;140(6):1017-30. doi: 10.1097/AOG.0000000000005000

Forns J, Danysh HE, McQuay LJ, Turner ME, Dempsey C, Anthony MS, Demos G, Layton JB. Clinical outcomes and treatment patterns of older adults with dementia‑related psychosis by dementia type in the United States. BMC geriatr. 2022 Oct 6;22(1):784. doi: 10.1186/s12877-022-03489-3.

Bradley Layton J, McQuay L, Forns J, Danysh H, Dempsey C, Anthony MS, Turner ME. Risk of mortality associated with pimavanserin compared with atypical antipsychotics in patients with Parkinson's disease–related psychosis. Presented at the 2022 ICPE Conference; August 27, 2022. Copenhagen, Denmark. Previously presented at the 2022 American Society of Clinical Psychopharmacology (ASCP).

Margulis AV, Calingaert B, Kawai AT, Rivero-Ferrer E, Anthony MS. Distribution of gestational age by maternal and infant characteristics in US birth certificate data: toward informing gestational age assumptions when clinical estimates are not available. Poster presented at the 2022 ICPE Conference; August 26, 2022. Copenhagen, Denmark.

Gatz JL, Armstrong MA, Postlethwaite D, Raine-Bennett T, Chillemi G, Alabaster A, Merchant M, Reed SD, Ichikawa L, Getahun D, Fassett MJ, Shi JM, Xie F, Chiu VY, Im TM, Takhar HS, Wang J, Saltus CW, Ritchey ME, Asiimwe A, Pisa F, Schoendorf J, Wahdan Y, Zhou X, Hunter S, Anthony MS, Peipert JF. Association between intrauterine device type and risk of perforation and device expulsion: results from the APEX-IUD study. Am J Obstet Gynecol. 2022 Jul 1;227(1):57.e1-57.. doi: 10.1016/j.ajog.2022.03.062

Reed SD, Zhou X, Ichikawa L, Gatz JL, Peipert JF, Armstrong MA, Raine-Bennett T, Getahun D, Fassett MJ, Postlethwaite DA, Shi JM, Asiimwe A, Pisa F, Schoendorf J, Saltus CW, Anthony MS, APEX-IUD study team. Intrauterine device-related uterine perforation incidence and risk (APEX-IUD): a large multisite cohort study. Lancet. 2022 Jun 4;399(10341):2103-12. doi: 10.1016/S0140-6736(22)00015-0

Getahun D, Fassett MJ, Gatz J, Armstrong MA, Peipert JF, Raine-Bennett T, Reed SD, Zhou X, Schoendorf J, Postlethwaite D, Shi JM, Saltus CW, Wang J, Xie F, Chiu VY, Merchant M, Alabaster A, Ichikawa LE, Hunter S, Im TM, Takhar HS, Ritchey ME, Chillemi G, Pisa F, Asiimwe A, Anthony MS. Association between menorrhagia and risk of intrauterine device-related uterine perforation and device expulsion: results from the APEX-IUD Study. Am J Obstet Gynecol. 2022 Jun;399(10341):2103-12. doi: 10.1016/j.ajog.2022.03.025

Layton JB, McQuay L, Forns J, Danysh HE, Dempsey C, Anthony MS, Turner ME. Risk of mortality associated with pimavanserin compared with atypical antipsychotics in patients with Parkinson's disease–related psychosis. Presented at the 2022 American Society of Clinical Psychopharmacology (ASCP); May 31, 2022. Scottsdale, AZ.

Forns J, Danysh H, McQuay L, Turner ME, Dempsey C, Anthony M, Layton B. Natural history of dementia-related psychosis and antipsychotic treatment patterns in older adults in the United States. Presented at the International Conference on Alzheimer's and Parkinson's Diseases 2022; March 18, 2022. Barcelona, Spain.

Layton JB, Forns J, Turner ME, Dempsey C, Bartsch JL, Anthony MS, Danysh HE, Ritchey ME, Demos G. Falls and fractures in patients with Parkinson's Disease–related psychosis treated with Pimavanserin vs atypical antipsychotics: a cohort study. Drugs Real World Outcomes. 2022 Mar;9(1):9-22. doi: 10.1007/s40801-021-00284-1

Armstrong MA, Raine-Bennett T, Reed SD, Gatz J, Getahun D, Schoendorf J, Postlethwaite D, Fassett MJ, Peipert JF, Saltus CW, Merchant M, Alabaster A, Zhou X, Ichikawa L, Shi JM, Chiu VY, Xie F, Hunter S, Wang J, Ritchey ME, Chillemi G, Im TM, Takhar HS, Pisa F, Asiimwe A, Anthony MS. Association of the timing of postpartum intrauterine device insertion and breastfeeding with risks of intrauterine device expulsion. JAMA Netw Open. 2022 Feb 28;5(2):e2148474. doi: 10.1001/jamanetworkopen.2021.48474

Beachler DC, Taylor DH, Anthony MS, Yin R, Li L, Saltus CW, Li Lin, Shaunik A, Walsh KE, Rothman KJ, Johannes CB, Aroda VR, Carr W, Goldberg P, Accardi A, O'Shura JS, Sharma K, Juhaeri J, Lanes S, Wu C. Response to letter to the editor regarding “Development and validation of a predictive model algorithm to identify anaphylaxis in adults with type 2 diabetes in U.S. administrative claims data”. Pharmacoepidemiol Drug Saf. 2022 Jan;31(1):110-1. doi: 10.1002/pds.5376

Margulis AV, Kawai AT, Anthony MS, Rivero-Ferrer E. Perinatal pharmacoepidemiology: how often are key methodological elements reported in publications? Pharmacoepidemiol Drug Saf. 2022 Jan;31(1):61-71. doi: 10.1002/pds.5353

Beachler DC, Taylor DH, Anthony MS, Yin R, Li L, Saltus CW, Li Lin, Shaunik A, Walsh KE, Rothman KJ, Johannes CB, Aroda VR, Carr W, Goldberg P, Accardi A, O'Shura JS, Sharma K, Juhaeri J, Lanes S, Wu C. Development and validation of a predictive model algorithm to identify anaphylaxis in adults with type 2 diabetes in U.S. administrative claims data. Pharmacoepidemiol Drug Saf. 2021 Jul;30(7):918-26. doi: 10.1002/pds.5257

Anthony MS, Reed SD, Armstrong MA, Getahun D, Gatz JL, Saltus CW, Zhou X, Schoendorf J, Postlethwaite DA, Raine-Bennett T, Fassett MJ, Peipert JF, Ritchey ME, Ichikawa LE, Lynen R, Alabaster AL, Merchant M, Chiu VY, Shi JM, Xie F, Hui SL, Wang J, Hunter S, Bartsch J, Frenz AK, Chillemi G, Im TM, Takhar HS, Asiimwe A. Design of the association of uterine perforation and expulsion of intrauterine device study: a multisite retrospective cohort study. Am J Obstet Gynecol. 2021 Jun;224(6):599.e1. doi: 10.1016/j.ajog.2021.01.003.

Forns J, Layton JB, Bartsch J, Turner ME, Dempsey C, Anthony M, Ritchey ME, Demos G. Increased risk of falls and fractures in patients with psychosis and Parkinson disease. PLoS One. 2021 Jan 27. doi: 10.1371/journal.pone.0246121

Reed S, Getahun D, Gatz J, Armstrong M, Raine-Bennett T, Zhou X, Fassett M, Peipert J, Saltus CW, Im T, Alabaster A, Hunter S, Takhar H, Chillemi G, Xie F, Wang J, Chiu V, Frenz A, Shi J, Lynen R, Asiimwe A, Anthony MS. Postpartum timing of IUD insertion is associated with risk of uterine perforation: results from APEX IUD. Poster presented at the Society of Family Planning Virtual 2020 Annual Meeting; October 9, 2020. [abstract] Contraception. 2020 Oct; 102(4):302. doi: 10.1016/j.contraception.2020.07.099

Raine-Bennett TR, Gatz JL, Reed SD, Armstrong MA, Getahun D, Zhou X, Merchant M, Takhar HS, Ichikawa LE, Peipert JF, Saltus CW, Fassett MJ, Chillemi GA, Im TM, Lynen R, Shi JM, Wang J, Xie F, Hunter S, Chiu VY, Asiimwe A, Anthony MS. Postpartum timing of IUD insertion is associated with risk of IUD expulsion: results from APEX IUD. Poster presented at the Society of Family Planning Virtual 2020 Annual Meeting; October 9, 2020. [abstract] Contraception. 2020 Oct; 102(4):295-6.

Reed SD, Armstrong MA, Getahun D, Gatz JL, Raine-Bennett TR, Alabaster AL, Ichikawa L, Saltus CW, Xie F, Zhou X, Fassett MJ, Peipert JF, Merchant M, Chiu VY, Hunter S, Schoendorf J, Shi JM, Chillemi GA, Im TM, Takhar HS, Asiimwe A, Anthony MS. Risk of uterine perforation and expulsion associated with breastfeeding among postpartum women with an intrauterine device insertion: results from APEX IUD. Poster presented at the Society of Family Planning Virtual 2020 Annual Meeting; October 9, 2020. [abstract] Contraception. 2020 Oct; 102(4):297.

Ritchey ME, Gatz J, Merchant M, Fassett M, Reed S, Saltus C, Getahun D, Peipert J, Chillemi G, Bartsch J, Im T, Asiimwe A, Armstrong MA, Anthony M. Risk across postpartum timing of insertion in women with intrauterine devices. Poster presented at the 2020 36th ICPE International Virtual Conference on Pharmacoepidemiology & Therapeutic Risk Management; September 16, 2020.

Ritchey ME, Reed S, Alabaster A, Getahun D, Gatz J, Saltus C, Amstrong MA, Xie F, Wang J, Fassett M, Chillemi G, Peipert J, Hunter S, Ichikawa L, Asiimwe A, Anthony M. Are indicators of difficult insertion among women with intrauterine devices associated with uterine perforation and expulsion? Poster presented at the 2020 36th ICPE International Virtual Conference on Pharmacoepidemiology & Therapeutic Risk Management; September 16, 2020.

Beachler DC, Taylor DH, Anthony MS, Yin R, Li L, Saltus CW, Li Lin, Shaunik A, Walsh KE, Lanes S, Rothman KJ, Johannes C, Aroda V, Carr W, Goldberg P, Accardi A, Shane O'Shura J, Sharma K, Juhaeri J, Wu C. Development and validation of a machine learning algorithm to identify anaphylaxis in US administrative claims data. Presented at the 2020 36th ICPE International Virtual Conference on Pharmacoepidemiology & Therapeutic Risk Management; September 16, 2020.

Saltus C, Reed S, Peipert J, Fassett M, Merchant M, Asiimwe A, Ritchey ME, Xie F, Amstrong MA, Gatz N, Ichikawa L, Getahun D, Lynen R, Wang J, Hunter S, Chillemi G, Anthony M. IUD type and indicators of difficult insertion among women with intrauterine devices. Poster presented at the 2020 36th ICPE International Virtual Conference on Pharmacoepidemiology & Therapeutic Risk Management; September 16, 2020.

Saltus C, Asiimwe A, Peipert J, Reed S, Getahun D, Alabaster A, Ritchey ME, Ichikawa L, Gatz J, Chiu V, Merchant M, Fassett M, Frenz A-K, Armstrong MA, Wang J, Hunter S, Chillemi G, Anthony M. Assessing outcomes of uterine perforation and IUD expulsion before and after ICD-9-CM to ICD-10-CM transition in women with IUD insertions. Poster presented at the 2020 36th ICPE International Virtual Conference on Pharmacoepidemiology & Therapeutic Risk Management; September 16, 2020.

Margulis AV, Kawai AT, Anthony M, Rivero-Ferrer E. Pregnancy pharmacoepidemiology: how often are key methodological data elements reported in publications? Poster presented at the 2020 36th ICPE International Virtual Conference on Pharmacoepidemiology & Therapeutic Risk Management; September 16, 2020.

Anthony M, Getahun D, Amstrong MA, Gatz J, Asiimwe A, Saltus C, Reed S, Shi J, Alabaster A, Fassett M, Peipert J, Schoendorf J, Hunter S, Wang J, Chillemi G, Ritchey ME. Breastfeeding, postpartum timing, and indicators of difficult insertion among women with intrauterine devices. Poster presented at the 2020 36th ICPE International Virtual Conference on Pharmacoepidemiology & Therapeutic Risk Management; September 16, 2020.

Forns J, Layton JB, Bartsch J, Turner ME, Dempsey C, Anthony M, Ritchey ME, Demos G. Increased risk of falls and fractures in patients with psychosis and Parkinson disease. Poster presented at the 2020 36th ICPE International Virtual Conference on Pharmacoepidemiology & Therapeutic Risk Management; September 16, 2020.

Reed SD, Saltus CW, Getahun D, Schoendorf J, Armstrong MA, Peipert JF, Raine-Bennett TR, Ritchey ME, Ichikawa LE, Zhou X, Fassett MJ, Alabaster A, Xie F, Merchant M, Chiu VY, Shi JM, Frenz A-K, Im TM, Takhar HS, Lynen R, Asiimwe A, Anthony MS. Menorrhagia and risk of intrauterine device (IUD) expulsion and uterine perforation: results from the APEX IUD study. Presented at the Virtual 76th Scientific Congress of the American Society for Reproductive Medicine (ASRM); October 17, 2020. [abstract] Fertil Steril. 2020 Sep 1; 114(3 Suppl):e12. doi: 10.1016/j.fertnstert.2020.08.059

Anthony MS. Leveraging natural language processing techniques for regulatory submissions. Presented at the 2020 DIA Virtual Conference; June 16, 2020. Washington, DC.

Margulis AV, Anthony M, Rivero-Ferrer E. Drug safety in pregnancy: review of study approaches requested by regulatory agencies. Curr Epidemiol Rep. 2019 Sep;6(3):380-9. doi: 10.1007/s40471-019-00212-6

Saltus CW, Gatz J, Ritchey ME, Ichikawa LE, Armstrong MA, Alabster AL, Merchant M, Lynen R, Asiimwe A, Shi JM, Getahun DT, Xie F, Chiu VY, Anthony MS. Study of the association of uterine perforation and IUD expulsion with breastfeeding and postpartum timing at IUD insertion (APEX IUD) - study size estimation to actuality. Poster presented at the 35th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 27, 2019. Philadelphia, PA. [abstract] Pharmacoepidemiol Drug Saf. 2019 Aug 20; 28(S2):748. doi: 10.1002/pds.4864

Anthony MS, Armstrong MA, Getahun D, Scholes D, Gatz J, Schulze-Rath R, Postlethwaite D, Merchant M, Alabaster AL, Chillemi G, Raine-Bennett T, Xie F, Chiu VY, Im TM, Takhar HS, Fassett M, Grafton J, Cronkite D, Ichikawa L, Reed SD, Hui SL, Ritchey ME, Saltus CW, Andrews EB, Rothman KJ, Asiimwe A, Lynen R, Schoendorf J. Identification and validation of uterine perforation, intrauterine device expulsion, and breastfeeding in four health care systems with electronic health records. Clin Epidemiol. 2019 Jul 23;2019(11):635-43. doi: 10.2147/CLEP.S201044

Ritchey ME, Harding A, Hunter S, Peterson C, Sager PT, Kowey PR, Nguyen L, Thomas S, Cainzos-Achirica M, Rothman KJ, Andrews EB, Anthony MS. Cardiovascular safety during and after use of phentermine and topiramate. J Clin Endocrinol Metab. 2019 Feb 1;104(2):513-22. doi: 10.1210/jc.2018-01010

Saltus CW, Anthony MS, Armstrong MA, Postlethwaite D, Getahun D, Xie F, Gatz J, Grafton J, Merchant M, Ichikawa L, Fassett MJ, Schulze-Rath R, Asiimwe A. Validation of uterine perforation and intrauterine device expulsion in electronic health records. Poster presented at the 34th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 24, 2018. Prague, Czech Republic. [abstract] Pharmacoepidemiol Drug Saf. 2018 Aug; 27(S2):127-8. doi: 10.1002/pds.4629

Anthony MS, Getahun D, Alabaster AL, Cronkite D, Gatz J, Merchant M, Chiu VY, Armstrong MA, Ritchey ME, Fassett MJ, Schoendorf J, Asiimwe A. Feasibility of assessing breastfeeding status in electronic health records. Poster presented at the 34th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 24, 2018. Prague, Czech Republic. [abstract] Pharmacoepidemiol Drug Saf. 2018 Aug; 27(S2):122. doi: 10.1002/pds.4629

Ritchey ME, Hunter S, Peterson C, Nguyen L, Thomas S, Harding A, Andrews EB, Rothman KJ, Cainzos-Achirica M, Anthony MS. Cardiovascular safety of phentermine and topiramate in a United States claims database. Poster presented at the 34th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 26, 2018. Prague, Czech Republic. [abstract] Pharmacoepidemiol Drug Saf. 2018 Aug; 27(S2):449. doi: 10.1002/pds.4629

Rivero-Ferrer E, Martinez D, Rasouliyan L, Anthony MS, Margulis AV, Perez-Gutthann S. Do ICPE pregnancy abstracts make it to term? Poster presented at the 34th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 25, 2018. Prague, Czech Republic. [abstract] Pharmacoepidemiol Drug Saf. 2018 Aug; 27(S2):241. doi: 10.1002/pds.4629

Krueger WS, Anthony MS, Saltus CW, Margulis AV, Rivero-Ferrer E, Monz B, Hirst C, Wormser D, Andrews E. Evaluating the safety of medication exposures during pregnancy: a case study of study designs and data sources in multiple sclerosis. Drugs Real World Outcomes. 2017 Sep;4(3):139-49. doi: 10.1007/s40801-017-0114-9

Carman WJ, Accortt NA, Anthony MS, Iles J, Enger C. Pregnancy and infant outcomes including major congenital malformations among women with chronic inflammatory arthritis or psoriasis, with and without etanercept use. Pharmacoepidemiol Drug Saf. 2017 Sep;26(9):1109-18. doi: 10.1002/pds.4261

Krueger WS, Anthony MS, Saltus CW, Margulis AV, Rivero-Ferrer E, Monz B, Wormser D, Andrews E. Existing databases useful for pregnancy exposure and fetal outcomes research, case study in multiple sclerosis (MS). Poster presented at the 33rd ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 29, 2017. Montreal, Canada. [abstract] Pharmacoepidemiol Drug Saf. 2017 Aug; 26(Suppl 2):403. doi: 10.1002/pds

Anthony M, Calingaert B, McQuay LJ, Andrews E, McGrath L, Rothman KJ, Rivero-Ferrer E. Suicide, suicidal behavior, and mortality rates in patients with psoriasis in England. Presented at the 33rd ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 30, 2017. Montreal, Canada. [abstract] Pharmacoepidemiol Drug Saf. 2017 Aug; 26(Suppl 2):475. doi: 10.1002/pds

Ritchey ME, Jonsson Funk M, Anthony M, Noren GN, Thomas S, Dasgupta N. Promises and perils of machine learning: a real-world evidence fable. Presented at the 33rd ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 30, 2017. Montreal, Canada. [abstract] Pharmacoepidemiol Drug Saf. 2017 Aug; 26(Suppl 2):460. doi: 10.1002/pds

Krueger WS, Anthony MS, Monz B, Saltus C, Hirst C, Margulis AV, Andrews E. Pregnancy studies assessing drug exposure in populations with multiple sclerosis. Poster presented at the 32nd ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 27, 2016. Dublin, Ireland. [abstract] Pharmacoepidemiol Drug Saf. 2016 Aug; 25(Suppl 3):334.

Kimball AB, Schenfeld J, Accortt NA, Anthony MS, Rothman KJ, Pariser D. Cohort study of malignancies and hospitalised infectious events in treated and untreated patients with psoriasis and a general population in the United States. Br J Dermatol. 2015 Nov;173(5):1183-90. doi: 10.1111/bjd.14068

Wu JJ, Rowan CG, Bebchuk JD, Anthony MS. Total cholesterol, lipoprotein, and triglyceride levels in tumor necrosis factor inhibitor-treated patients with psoriasis, psoriatic arthritis, or rheumatoid arthritis. Int J Dermatol. 2015 Oct;54(10):e442-5. doi: 10.1111/ijd.12921

Carman WJ, Accortt NA, Zhou L, Sanders L, Anthony MS, Enger C. Performance of an algorithm for identifying pregnancy outcomes in commercial health plan claims data. Poster presented at the 31st ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2015. Boston, MA.

Carman WJ, Accortt NA, Zhou L, Sanders LA, Anthony MS, Enger C. Performance of an algorithm for determining dates of conception and pregnancy termination dates using commercial health plan claims data. Poster presented at the 31st ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2015. Boston, MA.

Wu JJ, Rowan CG, Bebchuk JD, Anthony MS. Association between tumor necrosis factor inhibitor (TNFi) therapy and changes in C-reactive protein (CRP), blood pressure, and alanine aminotransferase (ALT) among patients with psoriasis, psoriatic arthritis, or rheumatoid arthritis. Letter to the editor. J Am Acad Dermatol. 2015 May;72(5):917-9.